Journal of Nanobiotechnology · 2022 · 38 citations · 31 references
Life SciencesMicrobiologyNutritional SciencesDrug DeliveryNanobiotechnologyNanoparticle Drug DeliveryAlzheimer DiseaseNanobiomaterialsNanocarriers For TherapeuticsNanomaterials For Drug DeliveryNanomedicineOral NanocarriersGut Microbiota DysbiosisIntestinal UptakeIntranasal AdministrationIntranasal FormulationsMesoporous Silica NanomaterialsMesoporous Silica Nanoparticle Co-deliveryMesoporous Silica NanoparticlesTherapeutic Targeting Of Amyloid
BACKGROUND: Dysbiosis or imbalance of gut microbiota in Alzheimer's disease (AD) affects the production of short-chain fatty acids (SCFAs), whereas exogenous SCFAs supplementation exacerbates brain Aβ burden in APP/PS1 mice. Bifidobacterium is the main producer of SCFAs in the gut flora, but oral administration of Bifidobacterium is ineffective due to strong acids and bile salts in the gastrointestinal tract. Therefore, regulating the levels of SCFAs in the gut is of great significance for AD treatment. METHODS: We investigated the feasibility of intranasal delivery of MSNs-Bifidobacterium (MSNs-Bi) to the gut and their effect on behavior and brain pathology in APP/PS1 mice. RESULTS: Mesoporous silica nanospheres (MSNs) were efficiently immobilized on the surface of Bifidobacterium. After intranasal administration, fluorescence imaging of MSNs-Bi in the abdominal cavity and gastrointestinal tract revealed that intranasally delivered MSNs-Bi could be transported through the brain to the peripheral intestine. Intranasal administration of MSNs-Bi not only inhibited intestinal inflammation and reduced brain Aβ burden but also improved olfactory sensitivity in APP/PS1 mice. CONCLUSIONS: These findings suggested that restoring the balance of the gut microbiome contributes to ameliorating cognitive impairment in AD, and that intranasal administration of MSNs-Bi may be an effective therapeutic strategy for the prevention of AD and intestinal disease.
31
Sangjune Kim, Seung‐Hwan Kwon, Tae‐In Kam et al. · Neuron · 2019 · 1.4K citations · Full text
Annamaria Cattaneo, Nadia Cattane, Samantha Galluzzi et al. · Neurobiology of Aging · 2016 · 1.4K citations · Full text
Microbiota-derived short chain fatty acids modulate microglia and promote Aβ plaque deposition
Alessio Colombo, Rebecca Sadler, Gemma Llovera et al. · eLife · 2021 · 328 citations · Full text